Johnson Matthey Completes Sale of Research Chemicals (Alfa Aesar) Business to Thermo Fisher Scientific Inc.

This completes the transaction which was first announced on 25th June 2015

01 October 2015

Johnson Matthey, a global leader in sustainable technologies, announces that on 30th September 2015 it completed the sale of its Alfa Aesar Research Chemicals business to Thermo Fisher Scientific Inc. for £256 million in cash. This completes the transaction which was first announced on 25th June 2015.

Commenting on the transaction, Robert MacLeod, Chief Executive of Johnson Matthey said: "The divestment of the Research Chemicals business is a further step in delivering our long term strategy to focus the group on growth areas where we can apply our expertise in complex chemistry to create long term value for our shareholders."

 

Enquiries

Sally Jones, Director, Investor Relations and Corporate Communications 
+44 20 7269 8407

David Allchurch, Tulchan Communications 
+44 20 7353 4200